Deep Genomics
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Check the tech stack behind deepgenomics.com. Find a founder email at deepgenomics.com.
About
Deep Genomics is an AI-driven genetic medicines platform company that uses its Biological Foundation (BioFM) Model Platform to solve complex molecular design and target biology problems. This platform enables the discovery and development of novel genetic medicines by integrating AI model development, screening technologies, and lab-in-the-loop workflows. They aim to transform drug discovery by finding molecules and targets others would miss, accelerating the development of life-changing medicines for patients. Teams look it up for Biotech, Drug Discovery, Genomics.
Frequently asked
What does Deep Genomics do?
Deep Genomics is a Biotech company that offers Platform. Teams look it up for Drug Discovery, Genomics, AI-Driven Drug Discovery. It is based in Toronto, Canada and was founded in 2015. Public records show about 110 people and $241M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Deep Genomics raised?
Deep Genomics has raised a total of $241M in funding. The most recent round on record is Series C.
Where is Deep Genomics headquartered?
Deep Genomics is headquartered in Toronto, Canada.
When was Deep Genomics founded?
Deep Genomics was founded in 2015.
What industry does Deep Genomics operate in?
Deep Genomics operates in Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery, RNA Therapeutics.
How many employees does Deep Genomics have?
Deep Genomics has approximately 110 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.